Roble Belko & Company Inc Makes New Investment in GRAIL, Inc. $GRAL

Roble Belko & Company Inc acquired a new position in shares of GRAIL, Inc. (NASDAQ:GRAL) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,324 shares of the company’s stock, valued at approximately $68,000.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in GRAIL by 3.4% during the first quarter. Vanguard Group Inc. now owns 1,499,740 shares of the company’s stock worth $38,303,000 after buying an additional 48,645 shares in the last quarter. AQR Capital Management LLC grew its stake in GRAIL by 61.0% during the first quarter. AQR Capital Management LLC now owns 1,337,163 shares of the company’s stock worth $33,991,000 after buying an additional 506,440 shares in the last quarter. Wealthquest Corp acquired a new stake in GRAIL during the first quarter worth about $18,247,000. Aberdeen Group plc boosted its stake in shares of GRAIL by 34.9% in the 1st quarter. Aberdeen Group plc now owns 284,735 shares of the company’s stock valued at $7,272,000 after purchasing an additional 73,667 shares in the last quarter. Finally, Carnegie Investment Counsel acquired a new stake in shares of GRAIL in the 2nd quarter valued at approximately $8,520,000.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on GRAL. UBS Group set a $75.00 price target on shares of GRAIL in a research note on Friday, October 3rd. Canaccord Genuity Group raised their price target on shares of GRAIL from $75.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $60.00.

Insider Buying and Selling

In related news, CEO Robert P. Ragusa sold 7,239 shares of the firm’s stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total value of $498,622.32. Following the completion of the transaction, the chief executive officer owned 727,388 shares in the company, valued at $50,102,485.44. This trade represents a 0.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Joshua J. Ofman sold 81,385 shares of the firm’s stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $62.50, for a total transaction of $5,086,562.50. Following the completion of the transaction, the president owned 396,797 shares of the company’s stock, valued at approximately $24,799,812.50. This trade represents a 17.02% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 117,497 shares of company stock valued at $7,515,436. 1.85% of the stock is owned by company insiders.

GRAIL Price Performance

Shares of NASDAQ GRAL opened at $91.93 on Friday. The company has a 50 day simple moving average of $56.96 and a 200 day simple moving average of $44.58. The firm has a market cap of $3.31 billion, a PE ratio of -7.01 and a beta of 4.11. GRAIL, Inc. has a 1 year low of $13.22 and a 1 year high of $103.00.

GRAIL (NASDAQ:GRAL) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The business had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. As a group, research analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.